MDM2 and neoplasm: The transplanted tumor volumes in the co-treatment group of MCF-7/DOX models were significantly lower than those in the NS (P<0.001), DOX (P=0.004) and MDM2/MDMX inhibitor groups (P=0.011) since day 3 until mice executed (Figure 5A).